Pre-earnings options volume in Lexicon (LXRX) Pharmaceuticals is normal with calls leading puts 16:1. Implied volatility suggests the market is anticipating a move near 25.9%, or 17c, after results are released. Median move over the past eight quarters is 7.5%.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LXRX:
- Largest borrow rate increases among liquid names
- LXRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Biotech Alert: Searches spiking for these stocks today
- Lexicon Pharmaceuticals: Strategic Partnerships and Pipeline Advancements Drive Buy Rating
- Lexicon announces exclusive license agreement with Novo Nordisk for LX9851